Check-Cap Ltd

7CC

Company Profile

  • Business description

    Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.

  • Contact

    29 Abba Hushi Avenue
    P.O. Box 1271
    Mount Carmel
    Isfiya3009000
    ISR

    T: +972 48303400

    E: [email protected]

    https://www.check-cap.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    85

Stocks News & Analysis

stocks

AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event

We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.
stocks

The most popular ASX trades in FY26

A closer look at the stocks and ETFs that captured Aussie investors’ attention in FY26.
stocks

Chart of the Week: The CBA chart you can’t ignore

Where value remains in Australian banks.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,018.1041.40-0.46%
CAC 408,299.09138.80-1.64%
DAX 4024,763.12392.29-1.56%
Dow JONES (US)51,674.11544.47-1.04%
FTSE 10010,639.1777.80-0.73%
HKSE25,210.81318.151.28%
NASDAQ25,054.86636.04-2.48%
Nikkei 22566,422.60307.000.46%
NZX 50 Index13,795.3132.130.23%
S&P 5007,391.82107.14-1.43%
S&P/ASX 2008,839.0038.60-0.43%
SSE Composite Index3,876.789.740.25%

Market Movers